COO
The Cooper Companies, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Sell
-35/100
Last price
55.64
▼ 1.13 (1.99%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
56.46
Prev close
56.77
Day high
56.93
Day low
55.64
Volume
4.00M
Market cap
$10.73B
P/E (TTM)
19.53
52W range
51.01 – 89.83
Day trading desk
Gap from prior close
-0.55%
Prior close 56.77
VWAP
56.24
-1.06% from price
Relative volume
1.03×
Normal
Session range
3.15%
55.55 – 57.30
Position in range
5%
Near session low
ATR (14D)
1.48
2.67% of price
Prior day high
57.01
PDH
Prior day low
55.73
PDL
Bid / ask spread
—
Quote not published
Session volume
3.18M
Avg 3.10M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-0.35%
-2.3%
1M
-18.91%
-20.1%
3M
-18.93%
-23.5%
6M
-18.99%
-37.2%
YTD
-31.15%
-45.4%
1Y
-19.91%
-36.3%
3Y
-29.02%
-111.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on COO open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
1.20M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 16, 26 | KURZIUS LAWRENCE ERIK Director |
BUY | 10.00K | $549.32K | Direct |
| Sep 14, 26 | KURZIUS LAWRENCE ERIK Director |
BUY | 10.00K | $539.15K | Direct |
| Sep 14, 26 | ROSEBROUGH WALTER M JR Director |
BUY | 10.00K | $541.64K | Indirect |
| Sep 11, 26 | KEEL PAUL A Director |
BUY | 4.70K | $250.00K | Direct |
| Apr 1, 26 | JAY COLLEEN E Director |
— | 3.32K | — | Direct |
| Apr 1, 26 | RIVAS MARIA Director |
— | 3.32K | — | Direct |
| Apr 1, 26 | CARBONE BARBARA Director |
— | 3.05K | — | Direct |
| Apr 1, 26 | WEISS ROBERT S Director |
— | 3.65K | — | Direct |
| Apr 1, 26 | LUCCHESE CYNTHIA L Director |
— | 3.32K | — | Direct |
| Apr 1, 26 | MADDEN TERESA SMITH Director |
— | 3.32K | — | Direct |
| Apr 1, 26 | KURZIUS LAWRENCE ERIK Director |
— | 3.32K | — | Direct |
| Apr 1, 26 | ROSEBROUGH WALTER M JR Director |
— | 832 | — | Direct |
| Jan 12, 26 | JAY COLLEEN E Director |
CONVERSION | 7.06K | $278.32K | Direct |
| Jan 8, 26 | ANDREWS BRIAN G Chief Financial Officer |
— | 3.53K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ANDREWS BRIAN G |
Chief Financial Officer | 30.73K | Conversion of Exercise of derivative security |
JAY COLLEEN E |
Director | 39.91K | Conversion of Exercise of derivative security |
KOZY WILLIAM A |
Director | 31.15K | Conversion of Exercise of derivative security |
KURZIUS LAWRENCE ERIK |
Director | 31.10K | Purchase |
MCBRIDE DANIEL G |
Chief Operating Officer | 163.85K | Conversion of Exercise of derivative security |
ROSEBROUGH WALTER M JR |
Director | — | Purchase |
SHEFFIELD HOLLY R |
Officer | 43.26K | Conversion of Exercise of derivative security |
WARNER GERARD H, III |
Officer | 23.85K | Conversion of Exercise of derivative security |
WEISS ROBERT S |
Director | 550.46K | Conversion of Exercise of derivative security |
WHITE ALBERT G III |
Chief Executive Officer | 245.07K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$10.73B
Enterprise value$13.38B
Revenue (TTM)$4.24B
Gross profit$2.79B
EBITDA$932.00M
Net income$570.30M
EPS (TTM)$2.89
Free cash flow$542.65M
Total cash$154.70M
Total debt$2.80B
Book value / share$43.81
Shares outstanding190.16M
Float188.77M
Short % of float6.03%
Dividend yield0.00%
Beta (5Y)0.83
Valuation & profitability ratios
Trailing P/E19.53
Forward P/E12.02
PEG ratio0.53
Price / sales—
Price / book1.29
EV / revenue3.16
EV / EBITDA14.35
Gross margin65.93%
Operating margin20.82%
Profit margin13.46%
Return on equity6.84%
Return on assets2.73%
Debt / equity33.63
Current ratio1.22
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $4.09B | $3.90B | $3.59B | $3.31B | +5.1% |
| Operating revenue | $4.09B | $3.90B | $3.59B | $3.31B | +5.1% |
| Cost of revenue | $1.41B | $1.30B | $1.24B | $1.17B | +8.5% |
| Gross profit | $2.68B | $2.60B | $2.36B | $2.14B | +3.3% |
| Research & development | $172.20M | $155.10M | $137.40M | $110.30M | +11.0% |
| Selling, general & admin | $1.63B | $1.53B | $1.50B | $1.34B | +6.1% |
| Total operating expense | $2.00B | $1.89B | $1.82B | $1.63B | +5.8% |
| Operating income | $682.90M | $705.70M | $533.10M | $507.60M | -3.2% |
| Net interest income | -$100.00M | -$114.30M | -$105.30M | -$57.30M | +12.5% |
| Pre-tax income | $566.50M | $582.30M | $412.90M | $475.30M | -2.7% |
| Tax provision | $191.60M | $190.00M | $118.70M | $89.50M | +0.8% |
| Net income | $374.90M | $392.30M | $294.20M | $385.80M | -4.4% |
| Net income to common | $374.90M | $392.30M | $294.20M | $385.80M | -4.4% |
| Basic EPS | 1.88 | 1.97 | 1.49 | 1.96 | -4.3% |
| Diluted EPS | 1.87 | 1.96 | 1.48 | 1.94 | -4.6% |
| EBIT | $666.50M | $696.60M | $518.20M | $532.60M | -4.3% |
| EBITDA | $1.04B | $1.07B | $885.90M | $878.70M | -2.6% |
| Basic shares | 199.10M | 199.60M | 198.10M | 197.20M | -0.3% |
| Diluted shares | 200.00M | 200.40M | 199.20M | 198.80M | -0.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $110.60M | $107.60M | $120.80M | $138.20M | +2.8% |
| Cash & short-term investments | $110.60M | $107.60M | $120.80M | $138.20M | +2.8% |
| Accounts receivable | $829.00M | $717.00M | $609.70M | $557.80M | +15.6% |
| Inventory | $846.00M | $802.70M | $735.60M | $628.70M | +5.4% |
| Total current assets | $2.11B | $1.95B | $1.70B | $1.53B | +7.9% |
| Property, plant & equipment | $2.08B | $1.86B | $1.63B | $1.43B | +11.7% |
| Goodwill & intangibles | $5.44B | $5.63B | $5.33B | $5.49B | -3.4% |
| Total assets | $12.39B | $12.32B | $11.66B | $11.49B | +0.6% |
| Total current liabilities | $1.11B | $1.02B | $969.00M | $1.28B | +8.8% |
| Current debt | $47.10M | $32.20M | $44.40M | $395.70M | +46.3% |
| Long-term debt | $2.46B | $2.55B | $2.52B | $2.35B | -3.6% |
| Total debt | $2.51B | $2.58B | $2.57B | $2.76B | -3.0% |
| Total liabilities | $4.16B | $4.23B | $4.11B | $4.32B | -1.8% |
| Retained earnings | $7.64B | $7.27B | $6.88B | $6.58B | +5.2% |
| Shareholder equity | $8.24B | $8.08B | $7.55B | $7.17B | +1.9% |
| Working capital | $993.60M | $928.70M | $735.90M | $253.40M | +7.0% |
| Net tangible assets | $2.80B | $2.45B | $2.22B | $1.68B | +14.1% |
| Shares issued | 217.60M | 217.20M | 215.70M | 215.20M | +0.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $374.90M | $392.30M | $294.20M | $385.80M | -4.4% |
| Depreciation & amortisation | $377.40M | $375.10M | $367.70M | $346.10M | +0.6% |
| Stock-based compensation | $70.50M | $75.10M | $62.10M | $54.20M | -6.1% |
| Change in working capital | -$284.80M | -$333.70M | -$218.80M | -$174.00M | +14.7% |
| Operating cash flow | $796.10M | $709.30M | $607.50M | $692.40M | +12.2% |
| Capital expenditure | -$362.40M | -$421.20M | -$392.50M | -$242.00M | +14.0% |
| Investing cash flow | -$372.90M | -$764.60M | -$449.00M | -$1.83B | +51.2% |
| Share buybacks | -$290.10M | $0 | $0 | -$78.50M | — |
| Dividends paid | $0 | $0 | -$3.00M | -$3.00M | — |
| Financing cash flow | -$425.90M | $39.20M | -$173.90M | $1.19B | -1,186.5% |
| Free cash flow | $433.70M | $288.10M | $215.00M | $450.40M | +50.5% |
| End cash position | $110.60M | $107.70M | $120.90M | $138.60M | +2.7% |
| Line item | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.07B | $1.08B | $1.02B | $1.07B | $1.06B | -1.4% |
| Operating revenue | $1.07B | $1.08B | $1.02B | $1.07B | $1.06B | -1.4% |
| Cost of revenue | $354.30M | $346.10M | $328.90M | $414.30M | $368.30M | +2.4% |
| Gross profit | $711.90M | $735.40M | $695.20M | $650.80M | $692.00M | -3.2% |
| Research & development | $41.60M | $42.50M | $44.30M | $41.40M | $44.60M | -2.1% |
| Selling, general & admin | $401.30M | $676.20M | $390.20M | $419.20M | $421.70M | -40.7% |
| Total operating expense | $489.90M | $766.40M | $482.40M | $510.40M | $516.30M | -36.1% |
| Operating income | $222.00M | -$31.00M | $212.80M | $140.40M | $175.70M | +816.1% |
| Net interest income | -$21.50M | -$20.90M | -$22.40M | -$24.40M | -$25.40M | -2.9% |
| Pre-tax income | $201.80M | -$48.40M | $192.20M | $116.80M | $151.90M | +516.9% |
| Tax provision | -$231.00M | $29.50M | $61.40M | $32.20M | $53.60M | -883.1% |
| Net income | $432.80M | -$77.90M | $130.80M | $84.60M | $98.30M | +655.6% |
| Net income to common | $432.80M | -$77.90M | $130.80M | $84.60M | $98.30M | +655.6% |
| Basic EPS | 2.24 | -0.40 | 0.67 | 0.43 | 0.49 | +660.0% |
| Diluted EPS | 2.24 | -0.40 | 0.66 | 0.43 | 0.49 | +660.0% |
| EBIT | $223.30M | -$27.50M | $214.60M | $141.20M | $177.30M | +912.0% |
| EBITDA | $318.00M | $67.90M | $310.10M | $239.60M | $272.70M | +368.3% |
| Basic shares | 193.00M | 195.00M | 195.80M | 195.90M | 199.30M | -1.0% |
| Diluted shares | 193.40M | 195.00M | 196.70M | 198.10M | 200.00M | -0.8% |
| Line item | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $154.70M | $138.80M | $124.90M | $110.60M | $124.90M | +11.5% |
| Cash & short-term investments | $154.70M | $138.80M | $124.90M | $110.60M | $124.90M | +11.5% |
| Accounts receivable | $788.90M | $809.20M | $807.10M | $829.00M | $792.30M | -2.5% |
| Inventory | $911.50M | $896.40M | $876.40M | $846.00M | $881.00M | +1.7% |
| Total current assets | $2.28B | $2.30B | $2.13B | $2.11B | $2.14B | -0.8% |
| Property, plant & equipment | $2.14B | $2.13B | $2.12B | $2.08B | $1.99B | +0.6% |
| Goodwill & intangibles | $5.32B | $5.38B | $5.45B | $5.44B | $5.50B | -1.1% |
| Total assets | $12.67B | $12.48B | $12.42B | $12.39B | $12.38B | +1.5% |
| Total current liabilities | $1.87B | $1.80B | $1.60B | $1.11B | $1.01B | +3.4% |
| Current debt | $627.50M | $598.20M | $620.10M | $47.10M | $46.00M | +4.9% |
| Long-term debt | $1.91B | $1.86B | $1.88B | $2.46B | $2.43B | +3.0% |
| Total debt | $2.54B | $2.46B | $2.50B | $2.51B | $2.48B | +3.4% |
| Total liabilities | $4.34B | $4.24B | $4.06B | $4.16B | $4.02B | +2.4% |
| Retained earnings | $8.13B | $7.70B | $7.77B | $7.64B | $7.56B | +5.6% |
| Shareholder equity | $8.33B | $8.24B | $8.36B | $8.24B | $8.35B | +1.1% |
| Working capital | $414.90M | $495.10M | $538.10M | $993.60M | $1.13B | -16.2% |
| Net tangible assets | $3.01B | $2.86B | $2.92B | $2.80B | $2.86B | +5.2% |
| Shares issued | 190.10M | 217.91M | 217.90M | 217.60M | 217.61M | -12.8% |
| Line item | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $432.80M | -$77.90M | $130.80M | $84.60M | $98.30M | +655.6% |
| Depreciation & amortisation | $94.70M | $95.40M | $95.50M | $98.40M | $95.40M | -0.7% |
| Change in working capital | $55.50M | $91.60M | -$36.10M | -$25.10M | -$18.50M | -39.4% |
| Operating cash flow | $341.70M | $182.80M | $260.90M | $247.90M | $261.40M | +86.9% |
| Capital expenditure | -$68.70M | -$86.40M | -$102.20M | -$98.00M | -$96.90M | +20.5% |
| Investing cash flow | -$69.80M | -$90.00M | -$102.90M | -$98.80M | -$98.10M | +22.4% |
| Share buybacks | -$339.20M | -$15.50M | -$92.50M | -$196.80M | -$52.70M | -2,088.4% |
| Financing cash flow | -$252.90M | -$75.80M | -$147.90M | -$164.40M | -$156.30M | -233.6% |
| Free cash flow | $273.00M | $96.40M | $158.70M | $149.90M | $164.50M | +183.2% |
| End cash position | $154.90M | $139.00M | $125.00M | $110.60M | $124.90M | +11.4% |
Options analytics
Put / call volume
0.03
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
40.00
-29.1% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
527
Contracts, this expiry
Put volume
15
Contracts, this expiry
Heaviest call OI
40.00
0 contracts
Heaviest put OI
40.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | 1.12 | 1.15 | +2.7% |
| Apr 2026 | 1.09 | 1.21 | +10.5% |
| Jan 2026 | 1.03 | 1.10 | +7.0% |
| Oct 2025 | 1.11 | 1.15 | +3.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 1.07 | 15 | $1.07B | +0.3% |
| Next quarter | 1.10 | 8 | $1.05B | +3.0% |
| Current year | 4.53 | 16 | $4.24B | +3.6% |
| Next year | 4.69 | 16 | $4.41B | +4.1% |
Analyst targets & ownership
Mean target$66.21
High target$75.00
Low target$58.00
Implied upside19.00%
Analyst count14
ConsensusBUY
Strong buy / Buy2 / 3
Hold11
Sell / Strong sell0 / 0
Held by insiders0.63%
Held by institutions111.92%
Institutions holding984
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
56.41
-1.36% from price
SMA 20
55.81
+1.11% from price
SMA 50
66.42
-15.04% from price
SMA 100
66.76
-16.65% from price
SMA 200
71.13
-20.66% from price
EMA 12
56.81
-2.06% from price
EMA 26
59.47
-6.43% from price
EMA 50
63.01
-11.70% from price
RSI (14)
36.3
Neutral
MACD (12,26,9)
-2.65
Hist 0.75
ATR (14)
1.48
2.63% of price
Realised vol 30D
53.4%
Annualised
Bollinger upper
60.06
20, 2σ
Bollinger lower
51.56
20, 2σ
50 / 200 cross
Death
66.42 vs 71.13
Trend bias
Below 200
-20.66%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.50
Less volatile than market
Correlation to SPY
0.20
Largely independent
Realised vol 30D
53.4%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-36.8%
Peak to trough
Max drawdown 5Y
-52.1%
Peak to trough
ATR 14
1.48
2.63% of price
Beta (reported)
0.83
5Y monthly, from filing
Short interest
Shares short
10.01M
Prior 7.64M
Change vs prior
+31.1%
Shorts adding
% of float
6.03%
Normal
% of shares out
5.26%
Against total outstanding
Days to cover
3.0
Liquid
Float
188.77M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 15, 26 | Needham | MAINTAINED | Buy | Buy |
| Sep 11, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
| Sep 10, 26 | William Blair | DOWNGRADE | Outperform | Market Perform |
| Sep 10, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Sep 10, 26 | Stifel | MAINTAINED | Buy | Buy |
| Sep 10, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Sep 10, 26 | Piper Sandler | DOWNGRADE | Overweight | Neutral |
| Sep 10, 26 | JP Morgan | MAINTAINED | Neutral | Neutral |
| Sep 10, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Sep 10, 26 | B of A Securities | DOWNGRADE | Buy | Neutral |
| Sep 10, 26 | Baird | DOWNGRADE | Outperform | Neutral |
| Sep 10, 26 | Needham | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield0.01%
Payout ratio0.00%
Ex-dividend dateJul 26, 2023
Next pay dateAug 11, 2023
Last split4:1
Split dateFeb 20, 2024
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-09
Periodic Financial Reports
10-Q · 2026-06-05
Corporate Changes & Voting Matters
8-K · 2026-06-04
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-29
Corporate Changes & Voting Matters
8-K · 2026-05-04
Corporate Changes & Voting Matters
8-K · 2026-04-08
Periodic Financial Reports
10-Q · 2026-03-06
Corporate Changes & Voting Matters
8-K · 2026-03-05
Headlines
Cooper Companies Director Rosebrough Buys 10,000 Shares for $542,000. What Does His Move Say About This Eye Care Stock?
Motley Fool · 6h ago
Cooper Companies Director Kurzius Buys $549,300 in Shares. Is the Eye Care Stock About to Rally?
Motley Fool · 4d ago
New CooperVision® Consumer Insights Report Reveals Multifocal Contact Lenses Are Viewed as a Leading Anti-Aging Solution
PR Newswire · 6d ago
Seneca Polytechnic and CooperVision Canada open Contact Lens Centre of Excellence to help advance the future of vision care
GlobeNewswire · 8d ago
Is Jana Partners Right that Cooper (COO) Needs a Different Kind of Leadership?
Insider Monkey · 9d ago
Is Cooper Companies (COO) Undervalued After Opening Its New Vision Centre?
Simply Wall St. · 10d ago
COO Unveils New Innovation Hub & Lens Launch Plans to Aid CooperVision
Zacks · 13d ago
CooperCompanies (COO) Keeps CooperSurgical and Expands Buybacks. What Did the Strategic Review Reveal?
Insider Monkey · 13d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.